QC
LABU icon

Quadrature Capital’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Quadrature Capital’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-32,709
Closed -$2.94M – 1303
2024
Q4 		$2.94M Sell
32,709
-39,408
-55% -$4.64M 0.06% 257
2024
Q3 		$9.27M Buy
+72,117
New +$9.41M 0.21% 96

Other funds holding LABU

Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.37B AUM 19.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Quadrature Capital's LABU Position: Q1 2025 in Review

Quadrature Capital sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2025, closing a stake of 32,709 shares — an estimated $2.94M sold.

Quadrature Capital first reported a position in LABU in Q3 2024 and held it in 2 quarters. The position peaked at $9.27M in Q3 2024. 34 funds tracked by Wall St. Rank hold LABU as of Q1 2025.

  • Quadrature Capital reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2025 after selling out during the quarter.
  • Quadrature Capital sold 32,709 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2025, an estimated $2.94M.
  • Quadrature Capital first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2024 and held it in 2 quarters.
  • Quadrature Capital's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $9.27M in Q3 2024.
  • 34 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2025.

Based on Quadrature Capital's 13F filing for Q1 2025, filed 13 May 2025.